The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHSTN.L Regulatory News (HSTN)

  • There is currently no data for HSTN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Recommended Cash Acquisition

31 Jan 2020 14:32

RNS Number : 6257B
Hansteen Holdings plc
31 January 2020
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

 

FOR IMMEDIATE RELEASE

31 January 2020

RECOMMENDED CASH ACQUISITION

of

HANSTEEN HOLDINGS PLC

by

POTTER UK BIDCO LIMITED

 

Results of Court Meeting and General Meeting

 

On 18 December 2019, the boards of Hansteen Holdings PLC (Hansteen) and Potter UK Bidco Limited (Bidco), a newly-formed company indirectly owned by investment funds advised by affiliates of The Blackstone Group Inc. (Blackstone), announced that they had reached agreement on the terms of a recommended cash acquisition by Bidco of the entire issued and to be issued ordinary share capital of Hansteen (the Acquisition). The Acquisition is to be effected by means of a Court approved scheme of arrangement under Part 26 of the Companies Act 2006 (the Scheme).

 

Hansteen is pleased to announce that, at the Court Meeting and the General Meeting (the Meetings) convened in relation to the proposed Scheme and held earlier today, all resolutions proposed, details of which are set out in the notices of the Meetings contained in Parts X and XI of the scheme document dated 10 January 2020 (the Scheme Document), were passed by the requisite majorities and accordingly the Scheme was approved.

 

A majority in number of the Scheme Shareholders who voted (either in person or by proxy), representing not less than 75 per cent. in value of the Scheme Shares held by Scheme Shareholders approved the Scheme at the Court Meeting.

 

Hansteen Shareholders voted at the General Meeting to pass the special resolution in connection with the amendment of the Company's articles of association and authorised the directors of Hansteen to take all such action as they may consider necessary or appropriate for carrying the Scheme into effect.

 

Voting results of the Court Meeting

 

The table below sets out the results of the poll at the Court Meeting. Each Scheme Shareholder, present in person or by proxy, was entitled to one vote per Scheme Share held at the Scheme Voting Record Time:

 

 

Results of Court Meeting

Number of Scheme Shares voted

% of Scheme Shares voted (2 d.p.)

Number of Scheme Shareholders who voted

% of Scheme Shareholders who voted (2 d.p.)

Number of Scheme Shares voted as a % of the issued ordinary share capital (2 d.p.)

FOR

234,685,853

99.26

283

92.79

54.92

AGAINST

1,751,491

0.74

22

7.21

0.41

TOTAL

236,437,344

100

305

100

55.33

 

 

Voting results of the General Meeting

 

The table below sets out the results of the poll at the General Meeting. Each Hansteen Shareholder, present in person or by proxy, was entitled to one vote per Hansteen Share held at the Scheme Voting Record Time:

 

Special Resolution

No. of Hansteen Shareholders voting

No. of Hansteen Shares voted

% of votes cast (2 d.p.)

FOR

277

234,568,328

99.27

AGAINST

24

1,730,584

0.73

WITHHELD*

2

11,073

n/a

*A withheld vote is not a vote in law and, accordingly, is not counted in the calculation of the proportion of votes "For" and "Against" the resolution concerned. Any proxy appointments which gave discretion to the Chairman have been included in the vote "For" total.

 

Effective Date and Timetable

 

The outcome of today's Court Meeting and General Meeting means that Conditions 1.1 and 1.2 (as set out in Part A of Part III of the Scheme Document) have been satisfied.

 

The Scheme remains subject to the sanction by the Court at the Court Hearing and the satisfaction (or, where applicable, waiver) of the other Conditions to the Scheme and the Acquisition (as set out in Part A of Part III of the Scheme Document). The Court Hearing is scheduled to take place at 10.30 a.m. on 4 February 2020.

 

The expected timetable of principal events for the implementation of the Scheme remains as set out on page 11 of the Scheme Document.

 

Subject to obtaining the approval of the Court, and the satisfaction or, where applicable, the waiver of the other Conditions (as set out in the Scheme Document), the Scheme is expected to become effective on 6 February 2020.

 

If any of the key dates set out in the timetable change, Hansteen will give notice of this change by issuing an announcement through a Regulatory Information Service and by making such announcement available on Hansteen's website at https://www.hansteen.co.uk/investors.

 

Full details of the Scheme are set out in the Scheme Document. Unless otherwise defined, all capitalised terms in this announcement shall have the meaning given to them in the Scheme Document.

Enquiries

Hansteen

Ian Watson

Morgan Jones

 

+44 (0)20 7408 7000

Peel Hunt (Financial adviser to Hansteen)

Capel Irwin

Michael Nicholson

Harry Nicholas

 

+44 (0)20 7418 8900

Tavistock Communications (PR adviser to Hansteen)

Jeremy Carey

Simon Hudson

 

+44 (0)20 7920 3150

Bidco

Ramesh Chhabra

Alexandra Ritterman

 

+44 (0)20 7451 4195

Rothschild & Co (Financial Adviser to Blackstone and Bidco)

Alex Midgen

Sam Green

+44 (0)20 7280 5000

Important notices relating to financial advisers

 

Peel Hunt LLP (Peel Hunt), which is authorised and regulated by the Financial Conduct Authority in the United Kingdom, is acting exclusively for Hansteen and for no one else in connection with the Acquisition and any other matter referred to in this announcement and will not be responsible to anyone other than Hansteen for providing the protections afforded to its clients or for providing advice in relation to the Acquisition or other matters referred to in this announcement.

 

N.M. Rothschild & Sons Limited (Rothschild & Co), which is authorised and regulated by the Financial Conduct Authority in the United Kingdom, is acting exclusively for Blackstone and Bidco and for no one else in connection with the subject matter of this announcement and will not be responsible to anyone other than Blackstone and Bidco for providing the protections afforded to its clients or for providing advice in connection with the subject matter of this announcement.

 

Further information

 

This announcement is not intended to and does not constitute, or form part of, an offer, invitation or the solicitation of an offer to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of any securities, or the solicitation of any vote or approval in any jurisdiction, pursuant to the Acquisition or otherwise, nor shall there be any sale, issuance or transfer of securities of Hansteen in any jurisdiction in contravention of applicable law. The Acquisition will be made solely by means of the Scheme Document or any document by which the Acquisition is made, which will contain the full terms and conditions of the Acquisition including details of how to vote in respect of the Acquisition. Any vote in respect of the Scheme or other response in relation to the Acquisition should be made only on the basis on the information contained in the Scheme Document.

 

This announcement does not constitute a prospectus or a prospectus equivalent document.

 

This announcement has been prepared for the purposes of complying with English law, the rules of the London Stock Exchange, the Listing Rules and the City Code on Takeovers and Mergers and the information disclosed may not be the same as that which would have been disclosed if this announcement had been prepared in accordance with the laws and regulations of any jurisdictions outside the United Kingdom.

 

Overseas Shareholders

 

The release, publication or distribution of this announcement in jurisdictions other than the United Kingdom or the United States may be restricted by law and/or regulations. Persons who are not resident in the United Kingdom or the United States or who are subject to the laws and regulations of other jurisdictions should inform themselves of, and observe, any applicable requirements.

 

Unless otherwise determined by Bidco or required by the Takeover Code, and permitted by applicable law and regulation, the Acquisition shall not be made available, directly or indirectly, in, into or from a Restricted Jurisdiction where to do so would violate the laws in that jurisdiction and no person may vote in favour of the Acquisition by any such use, means, instrumentality or form within a Restricted Jurisdiction or any other jurisdiction if to do so would constitute a violation of the laws of that jurisdiction. Accordingly, copies of this announcement and all documents relating to the Acquisition are not being, and must not be, directly or indirectly, mailed or otherwise forwarded, distributed or sent in, into or from a Restricted Jurisdiction where to do so would violate the laws in that jurisdiction, and persons receiving this announcement and all documents relating to the Acquisition (including custodians, nominees and trustees) must not mail or otherwise forward, distribute or send them in, into or from such jurisdictions where to do so would violate the laws in those jurisdictions. If the Acquisition is implemented by way of a Takeover Offer (unless otherwise permitted by applicable law and regulation), such Takeover Offer may not be made available directly or indirectly, into or from a Restricted Jurisdiction where to do so would violate the laws in that jurisdiction.

 

The availability of the Acquisition to Hansteen Shareholders who are not resident in the United Kingdom (and, in particular, their ability to vote their Scheme Shares with respect to the Scheme at the Court Meeting, or to appoint another person as proxy to vote at the Court Meeting on their behalf) may be affected by the laws of the relevant jurisdictions in which they are resident. Persons who are not resident in the United Kingdom should inform themselves of, and observe, any applicable requirements, as any failure to comply with such requirements may constitute a violation of the securities laws of any such jurisdiction. To the fullest extent permitted by applicable law, the companies and persons involved in the Acquisition disclaim any responsibility or liability for the violation of such restrictions by any person. The Acquisition shall be subject to the applicable requirements of the Takeover Code, the Panel, the London Stock Exchange, the Financial Conduct Authority and the Listing Rules. Further details in relation to Overseas Shareholders are contained in the Scheme Document.

 

This announcement does not constitute a prospectus or prospectus equivalent document.

 

Additional Information for US Investors

 

The Acquisition is being made to acquire the securities of an English company by means of a scheme of arrangement provided for under the laws of England and Wales. A transaction effected by means of a scheme of arrangement is not subject to the proxy solicitation or tender offer rules under the US Exchange Act. Accordingly, the Scheme will be subject to disclosure requirements and practices applicable in the United Kingdom to schemes of arrangement, which are different from the disclosure requirements of the US under the US Exchange Act. The financial information included in this announcement and the Scheme documentation has been or will have been prepared in accordance with accounting standards applicable in the UK and thus may not be comparable to financial information of US companies or companies whose financial statements are prepared in accordance with generally accepted accounting principles in the US.

 

If Bidco were to elect to implement the Acquisition by means of a Takeover Offer, such Takeover Offer would be made in compliance with applicable US laws and regulations, including to the extent applicable Section 14(e) of the US Exchange Act and Regulation 14E thereunder, and in accordance with the Takeover Code. Such a takeover would be made in the United States by Bidco and no one else. Accordingly, the Acquisition would be subject to disclosure and other procedural requirements, including with respect to withdrawal rights, offer timetable, settlement procedures and timing of payments that are different from those applicable under US domestic tender offer procedures and law.

 

The receipt of cash pursuant to the Acquisition by a US holder as consideration for the transfer of its Scheme Shares pursuant to the Scheme will likely be a taxable transaction for United States federal income tax purposes and under applicable United States state and local, as well as foreign and other, tax laws. Each Hansteen Shareholder is urged to consult his independent professional adviser immediately regarding the tax consequences of the Acquisition applicable to him.

 

It may be difficult for US holders to enforce their rights and claims arising out of the US federal securities laws, since Hansteen is located in a country other than the US, and all of its officers and directors are residents of countries other than the US. US holders may not be able to sue a non-US company or its officers or directors in a non-US court for violations of US securities laws. Further, it may be difficult to compel a non-US company and its affiliates to subject themselves to a US court's judgement.

 

In accordance with normal UK practice and consistent with Rule 14e-5(b) under the US Exchange Act, Bidco, certain affiliated companies and the nominees or brokers (acting as agents) may make certain purchases of, or arrangements to purchase, shares in Hansteen outside of the US, other than pursuant to the Acquisition, until the date on which the Acquisition and/or Scheme becomes effective, lapses or is otherwise withdrawn. If such purchases or arrangements to purchase were to be made they would occur either in the open market at prevailing prices or in private transactions at negotiated prices and comply with applicable law, including to the extent applicable the US Exchange Act. Any information about such purchases or arrangements to purchase will be disclosed as required in the United Kingdom, will be reported to a Regulatory Information Service and will be available on the London Stock Exchange website at www.londonstockexchange.com.

 

In accordance with the Code, normal United Kingdom market practice and Rule 14e-5(b) of the US Exchange Act, Peel Hunt and its affiliates will continue to act as an exempt principal trader in Hansteen securities on the London Stock Exchange. These purchases and activities by exempt principal traders which are required to be made public in the United Kingdom pursuant to the Code will be reported to a Regulatory Information Service and will be available on the London Stock Exchange website at www.londonstockexchange.com. This information will also be publicly disclosed in the United States to the extent that such information is made public in the United Kingdom.

 

Forward Looking Statements

 

This announcement (including information incorporated by reference in the announcement), oral statements made regarding the Acquisition, and other information published by Bidco and Hansteen contain certain forward-looking statements, beliefs or opinions, with respect to the financial condition, results of operations and business of Bidco and Hansteen. These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements often use words such as "anticipate", "target", "expect", "envisage", "estimate", "intend", "plan", "goal", "believe", "hope", "aims", "continue", "will", "may", "should", "would", "could", or other words of similar meaning. These statements are based on assumptions and assessments made by Hansteen, and/or Bidco, in light of their experience and their perception of historical trends, current conditions, future developments and other factors they believe appropriate. By their nature, forward-looking statements involve risk and uncertainty, because they relate to events and depend on circumstances that will occur in the future and the factors described in the context of such forward-looking statements in this announcement could cause actual results and developments to differ materially from those expressed in or implied by such forward-looking statements. Although it is believed that the expectations reflected in such forward-looking statements are reasonable, no assurance can be given by Hansteen and Bidco that such expectations will prove to have been correct and you are therefore cautioned not to place undue reliance on these forward-looking statements which speak only as at the date of this announcement. Neither Hansteen nor Bidco assumes any obligation and Hansteen and Bidco disclaim any intention or obligation, to update or correct the information contained in this announcement (whether as a result of new information, future events or otherwise), except as required by applicable law or regulation (including under the Listing Rules and the Disclosure Guidance and Transparency Rules of the FCA).

 

EXCEPT AS EXPRESSLY PROVIDED IN THIS ANNOUNCEMENT, THE FORWARD-LOOKING STATEMENTS HAVE NOT BEEN REVIEWED BY THE AUDITORS OF HANSTEEN, BLACKSTONE OR BIDCO OR THEIR RESPECTIVE FINANCIAL ADVISERS. SUCH FORWARD-LOOKING STATEMENTS INVOLVE KNOWN AND UNKNOWN RISKS AND UNCERTAINTIES THAT COULD SIGNIFICANTLY AFFECT EXPECTED RESULTS AND ARE BASED ON CERTAIN KEY ASSUMPTIONS. THERE ARE SEVERAL FACTORS WHICH COULD CAUSE ACTUAL RESULTS TO DIFFER MATERIALLY FROM THOSE EXPRESSED OR IMPLIED IN FORWARD-LOOKING STATEMENTS. AMONG THE FACTORS THAT COULD CAUSE ACTUAL RESULTS TO DIFFER MATERIALLY FROM THOSE DESCRIBED IN THE FORWARD-LOOKING STATEMENTS IS THE SATISFACTION OF THE CONDITIONS, AS WELL AS ADDITIONAL FACTORS SUCH AS CHANGES IN GLOBAL, POLITICAL, ECONOMIC, BUSINESS, COMPETITIVE, MARKET AND REGULATORY FORCES, FUTURE EXCHANGE AND INTEREST RATES, CHANGES IN TAX RATES AND FUTURE BUSINESS COMBINATIONS OR DISPOSITIONS. SUCH FORWARD LOOKING STATEMENTS SHOULD THEREFORE BE CONSTRUED IN THE LIGHT OF SUCH FACTORS. NEITHER BIDCO NOR HANSTEEN, NOR ANY OF THEIR RESPECTIVE ASSOCIATES OR DIRECTORS, OFFICERS OR ADVISERS, PROVIDES ANY REPRESENTATION, ASSURANCE OR GUARANTEE THAT THE OCCURRENCE OF THE EVENTS EXPRESSED OR IMPLIED IN ANY FORWARD-LOOKING STATEMENTS IN THIS ANNOUNCEMENT WILL ACTUALLY OCCUR.

 

Rounding

 

Certain figures included in this announcement have been subjected to rounding adjustments. Accordingly, figures shown for the same category presented in different tables may vary slightly and figures shown as totals in certain tables may not be an arithmetic aggregation of the figures that precede them.

 

No profit forecasts or estimates

 

No statement in this announcement is intended as a profit forecast or estimate for any period and no statement in this announcement should be interpreted to mean that earnings or earnings per share for Hansteen for the current or future financial years would necessarily match or exceed the historical published earnings or earnings per share for Hansteen.

 

 

Disclosure Requirements of the Takeover Code

 

Under Rule 8.3(a) of the Takeover Code, any person who is interested in 1 per cent. or more of any class of relevant securities of an offeree company or of any securities exchange offeror (being any offeror other than an offeror in respect of which it has been announced that its offer is, or is likely to be, solely in cash) must make an Opening Position Disclosure following the commencement of the offer period and, if later, following the announcement in which any securities exchange offeror is first identified. An Opening Position Disclosure must contain details of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of: (i) the offeree company; and (ii) any securities exchange offeror(s). An Opening Position Disclosure by a person to whom Rule 8.3(a) applies must be made by no later than 3.30 p.m. (London time) on the 10th Business Day following the commencement of the offer period and, if appropriate, by no later than 3.30 p.m. (London time) on the 10th Business Day following the announcement in which any securities exchange offeror is first identified. Relevant persons who deal in the relevant securities of the offeree company or of a securities exchange offeror prior to the deadline for making an Opening Position Disclosure must instead make a Dealing Disclosure.

 

Under Rule 8.3(b) of the Takeover Code, any person who is, or becomes, interested in 1 per cent. or more of any class of relevant securities of the offeree company or of any securities exchange offeror must make a Dealing Disclosure if the person deals in any relevant securities of the offeree company or of any securities exchange offeror. A Dealing Disclosure must contain details of the dealing concerned and of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of: (i) the offeree company; and (ii) any securities exchange offeror(s), save to the extent that these details have previously been disclosed under Rule 8. A Dealing Disclosure by a person to whom Rule 8.3(b) applies must be made by no later than 3.30 p.m. (London time) on the Business Day following the date of the relevant dealing.

 

If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire or control an interest in relevant securities of an offeree company or a securities exchange offeror, they will be deemed to be a single person for the purpose of Rule 8.3.

 

Opening Position Disclosures must also be made by the offeree company and by any offeror and Dealing Disclosures must also be made by the offeree company, by any offeror and by any persons acting in concert with any of them (see Rules 8.1, 8.2 and 8.4).

 

Details of the offeree and offeror companies in respect of whose relevant securities Opening Position Disclosures and Dealing Disclosures must be made can be found in the Disclosure Table on the Panel's website at www.thetakeoverpanel.org.uk, including details of the number of relevant securities in issue, when the offer period commenced and when any offeror was first identified. You should contact the Panel's Market Surveillance Unit on +44 (0)20 7638 0129 if you are in any doubt as to whether you are required to make an Opening Position Disclosure or a Dealing Disclosure.

 

Publication on website and availability of hard copies

 

A copy of this announcement will be made available, subject to certain restrictions relating to persons resident in Restricted Jurisdictions, free of charge on Hansteen's website at https://www.hansteen.co.uk/investors. For the avoidance of doubt, the contents of those websites are not incorporated into and do not form part of this announcement.

 

You may request a hard copy of the Scheme Document and all information incorporated into the Scheme Document by reference to another source by contacting Link Asset Services during normal business hours on 0371 664 0321 from within the UK or +44 (0)371 664 0321 if calling from outside the UK or by submitting a request in writing to Link Asset Services, PSX1, The Registry, 34 Beckenham Road, Beckenham, Kent, England BR3 4TU. Calls are charged at the standard geographic rate and will vary by provider. You may also request that all future documents, announcements and information to be sent to you in relation to the Acquisition should be in hard copy form.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCBSGDBRDXDGGB
Date   Source Headline
6th Feb 20209:30 amRNSScheme of Arrangement becomes effective
5th Feb 20203:20 pmRNSForm 8.3 - Hansteen Holdings plc
5th Feb 20203:17 pmRNSForm 8.3 - Hansteen Holdings PLC
5th Feb 20202:25 pmRNSForm 8.3 - Hansteen Holdings plc
5th Feb 20201:55 pmRNSHolding(s) in Company
5th Feb 20201:45 pmRNSForm 8.3 - [Hansteen Holdings plc]
5th Feb 202012:21 pmRNSForm 8.3 - Hansteen Holdings plc
5th Feb 202012:11 pmRNSForm 8.5 (EPT/RI) - Hansteen Holdings Plc
5th Feb 202010:30 amRNSIssue of Equity and Director/PDMR Shareholding
5th Feb 202010:26 amRNSForm 8 (DD) - Hansteen Holdings PLC
5th Feb 202010:25 amRNSRule 2.9 Announcement
5th Feb 202010:25 amRNSForm 8 (DD) -Hansteen Holdings PLC
5th Feb 202010:25 amRNSForm 8 (DD) - Hansteen Holdings PLC
5th Feb 20207:30 amRNSSuspension of Listing & Trading in Hansteen Shares
4th Feb 20203:20 pmRNSForm 8.3 - Hansteen Holdings plc
4th Feb 20202:28 pmEQSForm 8.3 - The Vanguard Group, Inc.: Hansteen Holdings plc
4th Feb 20202:25 pmRNSCourt Sanction of the Scheme
4th Feb 20201:36 pmRNSForm 8.3 - Hansteen Holdings plc
4th Feb 202012:41 pmRNSForm 8.3 - Hansteen Holdings plc
4th Feb 202011:25 amRNSForm 8.3 - Hansteen Holdings PLC
4th Feb 202011:18 amRNSForm 8.3 - Hansteen Holdings Plc
4th Feb 202010:56 amRNSForm 8.3 - Hansteen Holdings Plc
4th Feb 20209:09 amRNSForm 8.3 - HANSTEEN HOLDINGS PLC
4th Feb 20209:05 amRNSForm 8.3 - HANSTEEN HOLDINGS PLC
4th Feb 20208:21 amRNSChange to Time of Court Hearing
3rd Feb 20203:34 pmRNSForm 8.3 - Hansteen Holdings plc
3rd Feb 20203:20 pmRNSForm 8.3 - Hansteen Holdings plc
3rd Feb 20203:17 pmRNSForm 8.3 -Hansteen Holdings PLC
3rd Feb 20202:07 pmEQSForm 8.3 - The Vanguard Group, Inc.: Hansteen Holdings plc
3rd Feb 20202:04 pmRNSForm 8.3 - Hansteen Holdings plc
3rd Feb 202012:18 pmRNSForm 8.3 - Hansteen Holdings plc
3rd Feb 202012:17 pmRNSForm 8.3 - Hansteen Holdings plc
3rd Feb 202011:17 amRNSForm 8.3 - Hansteen Holdings Plc
3rd Feb 202010:45 amRNSForm 8.3 - HANSTEEN HOLDINGS PLC - Replacement
3rd Feb 202010:04 amRNSForm 8.3 - Hansteen Holdings PLC
3rd Feb 20208:57 amRNSForm 8.3 - HANSTEEN HOLDINGS PLC
31st Jan 20205:30 pmRNSHansteen Holdings
31st Jan 20203:20 pmRNSForm 8.3 - Hansteen Holdings plc
31st Jan 20202:32 pmRNSRecommended Cash Acquisition
31st Jan 20201:45 pmRNSForm 8.3 - [Hansteen Holdings plc]
31st Jan 20201:43 pmRNSForm 8.3 - Hansteen Holdings plc
31st Jan 20201:28 pmRNSForm 8.3 - Hansteen Holdings Plc
31st Jan 202011:30 amRNSForm 8.3 - Hansteen Holdings plc
30th Jan 20203:20 pmRNSForm 8.3 - Hansteen Holdings plc
30th Jan 20203:16 pmRNSForm 8.3 - Hansteen Holdings PLC
30th Jan 20201:33 pmRNSForm 8.3 - Hansteen Holdings plc
30th Jan 20201:18 pmEQSForm 8.3 - The Vanguard Group, Inc.: Hansteen Holdings plc
30th Jan 202012:18 pmRNSForm 8.3 - Hansteen Holdings Plc
30th Jan 202011:44 amRNSForm 8.3 - Hansteen Holdings plc
30th Jan 202011:21 amRNSForm 8.3 - Hansteen Holdings Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.